Back

Which kidney function estimate should guide anticoagulant dosing and risk assessment in atrial fibrillation?

EHJ - Open

16 September 2026
Organised by: Logo
Read full article
ESC Journals ARRHYTHMIAS AND DEVICE THERAPY CARDIOVASCULAR PHARMACOLOGY Atrial Fibrillation (AF)

Contributors

Chih-Min Liu
Chih-Min Liu

Author

Tze-Fan Chao
Tze-Fan Chao

Author

Taipei Veterans General Hospital Taipei , Taiwan

You may be interested in
thumbnail
Congress Presentation
Impact of kidney function overestimation by creatinine compared to cystatin C in patients with atrial fibrillation
12 April 2026
thumbnail
Congress Session
Stroke and bleeding risk in atrial fibrillation: walking the tight rope
25 August 2023
thumbnail
Congress Presentation
Direct oral anticoagulants: medication dosing errors in hospitalized patients with non-valvular atrial fibrillation and heart failure
20 May 2023
thumbnail
Congress Presentation
A new clinical decision support tool based on personalized evidence-based medicine improves outcomes of anticoagulation therapy in patients with atrial fibrillation: an analysis from the AF Registry
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources